Acasti Pharma reported $21.96M in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Acasti Pharma USD 21.96M 7.63M Sep/2026
Addus HomeCare USD 281.23M 2.92M Sep/2026
Amarin USD 612.88M 10.12M Sep/2026
Cassava Sciences USD 80.06M 3.67M Sep/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Option Care Health USD 1.31B 111.5M Sep/2026
Organigram Holdings CAD 280.09M 30M Jun/2026
Tilray USD 729.32M 28.18M Sep/2025